The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
National Comprehensive Cancer Network (NCCN) category I/FDA-approved metastatic pancreatic adenocarcinoma (mPDAC) treatments in commercially insured patients: an analysis of inpatient (IP) and emergency room (ER) admissions.
 
Paul Cockrum
Employment - Ipsen
Stock and Other Ownership Interests - Ipsen
 
Andy Surinach
Consulting or Advisory Role - Ipsen (Inst)
 
Stella Arndorfer
Consulting or Advisory Role - Ipsen (Inst)
 
Jim M. Koeller
Honoraria - Coherus BioSciences; Helsinn Healthcare; HERON; Merck; Pfizer
Consulting or Advisory Role - Daiichi Sankyo; Helsinn Healthcare; Ipsen; Merck; Tocagen
Speakers' Bureau - Coherus BioSciences; Helsinn Healthcare; HERON; Merck; Pfizer
Research Funding - Array BioPharma; Celgene
Travel, Accommodations, Expenses - Coherus BioSciences; Helsinn Healthcare; HERON; Merck; Pfizer
 
George P. Kim
No Relationships to Disclose